Verition Fund Management LLC purchased a new position in shares of HCA Healthcare Inc (NYSE:HCA) during the second quarter, HoldingsChannel reports. The firm purchased 2,498 shares of the company’s stock, valued at approximately $242,000.

A number of other hedge funds have also recently bought and sold shares of the stock. Public Employees Retirement Association of Colorado increased its position in shares of HCA Healthcare by 3.2% during the first quarter. Public Employees Retirement Association of Colorado now owns 50,903 shares of the company’s stock valued at $4,574,000 after acquiring an additional 1,602 shares during the last quarter. First Trust Advisors LP boosted its holdings in shares of HCA Healthcare by 30.2% in the first quarter. First Trust Advisors LP now owns 246,210 shares of the company’s stock worth $22,122,000 after acquiring an additional 57,171 shares during the period. Private Capital Group LLC boosted its stake in HCA Healthcare by 17.5% during the first quarter. Private Capital Group LLC now owns 866 shares of the company’s stock valued at $78,000 after buying an additional 129 shares during the period. Transcend Wealth Collective LLC bought a new stake in HCA Healthcare during the first quarter valued at $720,000. Finally, Frontier Wealth Management LLC boosted its stake in HCA Healthcare by 5.0% during the first quarter. Frontier Wealth Management LLC now owns 4,228 shares of the company’s stock valued at $380,000 after buying an additional 201 shares during the period. 68.28% of the stock is currently owned by institutional investors and hedge funds.

Several research firms recently issued reports on HCA. SunTrust Banks lifted their price objective on HCA Healthcare from $130.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Oppenheimer lifted their price objective on HCA Healthcare from $135.00 to $140.00 in a report on Thursday, July 23rd. BMO Capital Markets downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $121.00 to $100.00 in a report on Monday, July 13th. Zacks Investment Research downgraded HCA Healthcare from a “hold” rating to a “sell” rating and set a $103.00 price objective on the stock. in a report on Tuesday, June 23rd. Finally, Piper Sandler lifted their price objective on HCA Healthcare from $132.00 to $138.00 and gave the stock a “neutral” rating in a report on Thursday, July 23rd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $147.29.

Shares of NYSE HCA opened at $135.80 on Wednesday. HCA Healthcare Inc has a twelve month low of $58.38 and a twelve month high of $151.97. The firm has a market cap of $45.90 billion, a P/E ratio of 14.00, a PEG ratio of 1.20 and a beta of 1.40. The company has a 50 day moving average of $132.59 and a 200 day moving average of $111.31. The company has a quick ratio of 0.95, a current ratio of 1.09 and a debt-to-equity ratio of 54.19.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.23 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.94) by $4.17. HCA Healthcare had a net margin of 6.67% and a negative return on equity of 589.47%. The company had revenue of $11.07 billion during the quarter, compared to analyst estimates of $10.44 billion. During the same period in the previous year, the business earned $2.21 EPS. The firm’s revenue for the quarter was down 12.2% on a year-over-year basis. As a group, equities analysts expect that HCA Healthcare Inc will post 10.12 earnings per share for the current fiscal year.

In other HCA Healthcare news, insider A Bruce Moore, Jr. sold 15,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $133.73, for a total transaction of $2,005,950.00. Following the completion of the sale, the insider now directly owns 88,626 shares in the company, valued at approximately $11,851,954.98. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP P. Martin Paslick sold 227 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $134.97, for a total transaction of $30,638.19. Following the sale, the senior vice president now owns 2,621 shares of the company’s stock, valued at $353,756.37. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,481 shares of company stock valued at $2,070,363. 1.80% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: What does an outperform rating mean?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.